Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Onychomycosis Treatment Market from 2024 to 2033?

The onychomycosis treatment market has experienced strong growth in recent years, expected to rise from $3.39 billion in 2023 to $3.65 billion in 2024, reflecting a compound annual growth rate (CAGR) of 7.5%. This growth is driven by increasing fungal infections, an aging population, greater public awareness, a rising prevalence of onychomycosis, and growing disposable incomes.

The onychomycosis treatment market is anticipated to grow significantly, reaching $4.73 billion by 2028, with a compound annual growth rate (CAGR) of 6.7%. The growth is driven by factors such as an aging population, telemedicine expansion, combination therapies, increased healthcare access, changing lifestyles, environmental factors, and a higher prevalence of diabetes. Key trends include dermatological advancements, drug delivery innovations, personalized treatments, topical treatment developments, digital health solutions, and laser therapy.

Claim Your Free Sample of the Global Onychomycosis Treatment Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12941&type=smp

The rising cases of fungal infections are fueling growth in the onychomycosis treatment market, as fungal diseases affect various body parts. Onychomycosis (nail fungus) treatments, including oral and topical antifungals, are increasingly necessary. According to the CDC, in 2021, the U.S. recorded 3,270 clinical and 7,413 screening cases of Candida auris. Further, fungal infection deaths rose from 5,922 in 2020 to 7,199 in 2021, indicating increased demand for onychomycosis treatments.

1) By Type: Distal Sublingual Onychomycosis, White Superficial Onychomycosis, Proximal Sublingual Onychomycosis, Candida Onychomycosis, Other Types

2) By Treatment Type: Drugs, Laser Therapy, Photodynamic Therapy

3) By Age Group: 0 To 18 Years, 18 To 39 Years, 40 To 64 Years, 65 Years And Above

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

In the onychomycosis treatment market, companies are focused on developing and gaining approval for new treatments. Moberg Pharma AB, a Sweden-based pharmaceutical company, received European Union approval for MOB-015 in June 2023. MOB-015 is a topical terbinafine formulation designed to treat mild to moderate fungal nail infections. Clinical trials demonstrated improved cure rates, and the formulation allows effective concentrations to reach the nail without systemic exposure risks associated with oral treatments.

Order Now for Fast Delivery of Your Onychomycosis Treatment Market Report!

https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report

North America was the largest region in the central precocious puberty market in 2023. The regions covered in the central precocious puberty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Onychomycosis Treatment Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the onychomycosis treatment market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Onychomycosis Treatment Market Include

1. Onychomycosis Treatment Market Executive Summary

2. Onychomycosis Treatment Market Segments

3. Onychomycosis Treatment Market Size And Template Market Growth Rate

4. Key Onychomycosis Treatment Market Trends

5. Major Onychomycosis Treatment Market Drivers

……

25. Key Mergers And Acquisitions In The Onychomycosis Treatment Market

26. Top Onychomycosis Treatment Companies

27. Onychomycosis Treatment Market Opportunities And Strategies

28. Onychomycosis Treatment Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Generic Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Ethical Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ethical-pharmaceuticals-global-market-report

Biopharmaceuticals Contract Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: